3 Years Ago
1 Min Read
Shares of PGNY are trading 18% higher today. The primary reasons:
Shares of Progyny Inc (PGNY) are trading 18% higher at a price of $38.54 at the time of this writing.
- Q2 GAAP EPS: $0.09, beats by $0.05
- Revenue: $195M (+51.6% Y/Y), beats by $4.49M
- Increase in clients and covered lives
- Gross profit: +48% Y/Y to $43.9M
- Volume now back to the pre-COVID level
- Net income: -53% Y/Y to $8.8M
- Higher non-cash stock-based compensation expense
- Guidance, FY22 revenue: $750.0M-$775.0M vs consensus of $756.22M
- Guidance, Q3 revenue: $190.0M-$197.0M vs consensus of $191.86M.
Progyny Inc has been trading between a 52-week high of $68.32 and a 52-week low of $25.67. The stock has a market cap of $3.54 Billion.
Progyny is a leading fertility benefits management company in the US. The company is redefining fertility and family building benefits, proving that a comprehensive and inclusive fertility solution can simultaneously benefit employers, patients, and physicians.
Headlines
Progyny trades higher after Q2 results beat, lower end of FY22 revenue guidance raised
Seeking Alpha 08-04-22
HYZN, CLFD and ZFOX are among after hour movers
Seeking Alpha 08-04-22
Recap: Progyny Q2 Earnings
Benzinga 08-04-22
Progyny GAAP EPS of $0.09 beats by $0.05, revenue of $195M beats by $4.49M (NASDAQ:PGNY)
Seeking Alpha 08-04-22
Progyny, Inc. Announces Second Quarter 2022 Results
GlobeNewswire 08-04-22
Recommended Articles
